San Francisco Bay Area biotech stories.
Friday, June 10, 2011
Skin care therapy company Revance Therapeutics cleans up with $45M financing
Revance Therapeutics Inc. has closed a $45 million round of financing led by Palo Alto-based Essex Woodlands Health Ventures and a new investor, NovaQuest Capital, the company said Friday.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)